Effective Combination Immunotherapy with Oncolytic Adenovirus and Anti-PD-1 for Treatment of Human and Murine Ovarian Cancers

Camilla Heiniö; James Clubb; Tatiana Kudling; Dafne Quixabeira; Victor Cervera-Carrascon; Riikka Havunen; Susanna Grönberg-Vähä-Koskela; Joao Manuel Santos; Johanna Tapper; Anna Kanerva; Akseli Hemminki

doi:10.3390/diseases10030052

Effective Combination Immunotherapy with Oncolytic Adenovirus and Anti-PD-1 for Treatment of Human and Murine Ovarian Cancers

Camilla Heiniö, James Clubb, Tatiana Kudling, Dafne Quixabeira, Victor Cervera-Carrascon, Riikka Havunen, Susanna Grönberg-Vähä-Koskela, Joao Manuel Santos, Johanna Tapper, Anna Kanerva, Akseli Hemminki

Research output: Contribution to journal › Article › Scientific › peer-review

Original language	English
Article number	52
Journal	Viruses (Basel)
Volume	10
Issue number	3
Number of pages	16
ISSN	1999-4915
DOIs	https://doi.org/10.3390/diseases10030052
Publication status	Published - Sept 2022
MoE publication type	A1 Journal article-refereed

Fields of Science

ovarian cancer
oncolytic virus
immune checkpoint inhibitor
adenovirus
TILT-123
NECROSIS-FACTOR-ALPHA
FOLLOW-UP
THERAPY
CELLS
3122 Cancers
3111 Biomedicine

Access to Document

10.3390/diseases10030052

Effective Combination Immunotherapy with OncolyticFinal published version, 1.3 MBLicence: CC BY

Cite this

Heiniö, C., Clubb, J., Kudling, T., Quixabeira, D., Cervera-Carrascon, V., Havunen, R., Grönberg-Vähä-Koskela, S., Santos, J. M., Tapper, J., Kanerva, A., & Hemminki, A. (2022). Effective Combination Immunotherapy with Oncolytic Adenovirus and Anti-PD-1 for Treatment of Human and Murine Ovarian Cancers. Viruses (Basel), 10(3), Article 52. https://doi.org/10.3390/diseases10030052

@article{7973e8da94514ca08885c62169c49084,

title = "Effective Combination Immunotherapy with Oncolytic Adenovirus and Anti-PD-1 for Treatment of Human and Murine Ovarian Cancers",

keywords = "ovarian cancer, oncolytic virus, immune checkpoint inhibitor, adenovirus, TILT-123, NECROSIS-FACTOR-ALPHA, FOLLOW-UP, THERAPY, CELLS, 3122 Cancers, 3111 Biomedicine",

author = "Camilla Heini{\"o} and James Clubb and Tatiana Kudling and Dafne Quixabeira and Victor Cervera-Carrascon and Riikka Havunen and Susanna Gr{\"o}nberg-V{\"a}h{\"a}-Koskela and Santos, {Joao Manuel} and Johanna Tapper and Anna Kanerva and Akseli Hemminki",

year = "2022",

month = sep,

doi = "10.3390/diseases10030052",

language = "English",

volume = "10",

journal = "Viruses (Basel)",

issn = "1999-4915",

publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",

number = "3",

}

Heiniö, C, Clubb, J, Kudling, T, Quixabeira, D, Cervera-Carrascon, V, Havunen, R, Grönberg-Vähä-Koskela, S, Santos, JM, Tapper, J , Kanerva, A & Hemminki, A 2022, 'Effective Combination Immunotherapy with Oncolytic Adenovirus and Anti-PD-1 for Treatment of Human and Murine Ovarian Cancers', Viruses (Basel), vol. 10, no. 3, 52. https://doi.org/10.3390/diseases10030052

TY - JOUR

T1 - Effective Combination Immunotherapy with Oncolytic Adenovirus and Anti-PD-1 for Treatment of Human and Murine Ovarian Cancers

AU - Heiniö, Camilla

AU - Clubb, James

AU - Kudling, Tatiana

AU - Quixabeira, Dafne

AU - Cervera-Carrascon, Victor

AU - Havunen, Riikka

AU - Grönberg-Vähä-Koskela, Susanna

AU - Santos, Joao Manuel

AU - Tapper, Johanna

AU - Kanerva, Anna

AU - Hemminki, Akseli

PY - 2022/9

Y1 - 2022/9

KW - ovarian cancer

KW - oncolytic virus

KW - immune checkpoint inhibitor

KW - adenovirus

KW - TILT-123

KW - NECROSIS-FACTOR-ALPHA

KW - FOLLOW-UP

KW - THERAPY

KW - CELLS

KW - 3122 Cancers

KW - 3111 Biomedicine

U2 - 10.3390/diseases10030052

DO - 10.3390/diseases10030052

M3 - Article

SN - 1999-4915

VL - 10

JO - Viruses (Basel)

JF - Viruses (Basel)

IS - 3

M1 - 52

ER -